PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
VRSN vs. DVA
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between VRSN and DVA is 0.24, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

VRSN vs. DVA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in VeriSign, Inc. (VRSN) and DaVita Inc. (DVA). The values are adjusted to include any dividend payments, if applicable.

1,500.00%2,000.00%2,500.00%3,000.00%3,500.00%4,000.00%SeptemberOctoberNovemberDecember2025
3,871.70%
2,068.62%
VRSN
DVA

Key characteristics

Sharpe Ratio

VRSN:

0.34

DVA:

2.18

Sortino Ratio

VRSN:

0.63

DVA:

2.79

Omega Ratio

VRSN:

1.08

DVA:

1.38

Calmar Ratio

VRSN:

0.19

DVA:

3.34

Martin Ratio

VRSN:

0.73

DVA:

13.03

Ulcer Index

VRSN:

8.91%

DVA:

4.90%

Daily Std Dev

VRSN:

19.16%

DVA:

29.41%

Max Drawdown

VRSN:

-98.37%

DVA:

-92.91%

Current Drawdown

VRSN:

-15.99%

DVA:

-0.17%

Fundamentals

Market Cap

VRSN:

$20.66B

DVA:

$14.45B

EPS

VRSN:

$8.58

DVA:

$9.28

PE Ratio

VRSN:

25.06

DVA:

18.99

PEG Ratio

VRSN:

3.11

DVA:

1.31

Total Revenue (TTM)

VRSN:

$1.16B

DVA:

$9.52B

Gross Profit (TTM)

VRSN:

$1.02B

DVA:

$2.97B

EBITDA (TTM)

VRSN:

$858.40M

DVA:

$2.02B

Returns By Period

In the year-to-date period, VRSN achieves a 3.88% return, which is significantly lower than DVA's 17.82% return. Over the past 10 years, VRSN has outperformed DVA with an annualized return of 14.26%, while DVA has yielded a comparatively lower 8.69% annualized return.


VRSN

YTD

3.88%

1M

4.56%

6M

14.54%

1Y

7.72%

5Y*

0.05%

10Y*

14.26%

DVA

YTD

17.82%

1M

15.30%

6M

26.29%

1Y

58.44%

5Y*

16.98%

10Y*

8.69%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

VRSN vs. DVA — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

VRSN
The Risk-Adjusted Performance Rank of VRSN is 5454
Overall Rank
The Sharpe Ratio Rank of VRSN is 6060
Sharpe Ratio Rank
The Sortino Ratio Rank of VRSN is 5050
Sortino Ratio Rank
The Omega Ratio Rank of VRSN is 4848
Omega Ratio Rank
The Calmar Ratio Rank of VRSN is 5656
Calmar Ratio Rank
The Martin Ratio Rank of VRSN is 5656
Martin Ratio Rank

DVA
The Risk-Adjusted Performance Rank of DVA is 9393
Overall Rank
The Sharpe Ratio Rank of DVA is 9494
Sharpe Ratio Rank
The Sortino Ratio Rank of DVA is 9090
Sortino Ratio Rank
The Omega Ratio Rank of DVA is 9090
Omega Ratio Rank
The Calmar Ratio Rank of DVA is 9696
Calmar Ratio Rank
The Martin Ratio Rank of DVA is 9595
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

VRSN vs. DVA - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for VeriSign, Inc. (VRSN) and DaVita Inc. (DVA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for VRSN, currently valued at 0.34, compared to the broader market-2.000.002.000.342.18
The chart of Sortino ratio for VRSN, currently valued at 0.63, compared to the broader market-4.00-2.000.002.004.000.632.79
The chart of Omega ratio for VRSN, currently valued at 1.08, compared to the broader market0.501.001.502.001.081.38
The chart of Calmar ratio for VRSN, currently valued at 0.19, compared to the broader market0.002.004.006.000.193.34
The chart of Martin ratio for VRSN, currently valued at 0.73, compared to the broader market0.0010.0020.000.7313.03
VRSN
DVA

The current VRSN Sharpe Ratio is 0.34, which is lower than the DVA Sharpe Ratio of 2.18. The chart below compares the historical Sharpe Ratios of VRSN and DVA, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.004.00SeptemberOctoberNovemberDecember2025
0.34
2.18
VRSN
DVA

Dividends

VRSN vs. DVA - Dividend Comparison

Neither VRSN nor DVA has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

VRSN vs. DVA - Drawdown Comparison

The maximum VRSN drawdown since its inception was -98.37%, which is greater than DVA's maximum drawdown of -92.91%. Use the drawdown chart below to compare losses from any high point for VRSN and DVA. For additional features, visit the drawdowns tool.


-35.00%-30.00%-25.00%-20.00%-15.00%-10.00%-5.00%0.00%SeptemberOctoberNovemberDecember2025
-15.99%
-0.17%
VRSN
DVA

Volatility

VRSN vs. DVA - Volatility Comparison

The current volatility for VeriSign, Inc. (VRSN) is 4.91%, while DaVita Inc. (DVA) has a volatility of 5.78%. This indicates that VRSN experiences smaller price fluctuations and is considered to be less risky than DVA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


4.00%6.00%8.00%10.00%12.00%14.00%SeptemberOctoberNovemberDecember2025
4.91%
5.78%
VRSN
DVA

Financials

VRSN vs. DVA - Financials Comparison

This section allows you to compare key financial metrics between VeriSign, Inc. and DaVita Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab